Role of optimal medication given to patients with hypertension and ischemic heart disease prior to an acute coronary syndrome
Abstract
Overview
Introduction.
Administering optimal cardiovascular medication (OCM) to patients with hypertension (HBP) and
ischemic heart disease (IHD) lowers cardiovascular morbidity and mortality.
The main objective of this study was to compare in-hospital cardiac mortality among patients with HBP and/or
IHD, treated or untreated with OCM, who developed a first episode of acute coronary syndrome (ACS).
Methods.
The study was carried out retrospectively and included patients admitted with a first episode of ACS
between 2013 and 2016. The patients were divided into three groups: those with HBP, IHD, and a history of HBP +
IHD. Patients were then divided into two subgroups: subgroup A consisted of patients undergoing optimal anti-
ischemic and/or antihypertensive therapy, while subgroup B consisted of patients without OCM.
Results.
This analysis comprised 1096 patients. Mean age was 64.3 ± 18 years. There were 581 patients in subgroup A – 53%, and 515 patients in subgroup B – 47%. Total cardiac mortality was 9.98%, different depending
on the groups and subgroups studied: HBP group total – 7%, subgroup A – 5.1%, significantly lower compared
to subgroup B – 9.4% (p = 0.05); IHD group total – 12.2%, subgroup A – 9.07%, significantly lower compared to
subgroup B – 15.8% (p = 0.05); HBP + IHD group total – 14.35%, subgroup A – 9.9%, significantly lower compared
to subgroup B – 18.8% (p = 0.05).
Conclusions.
The lack of OCM in patients with HBP and/or IHD is correlated to a significant increase in in-hospital
cardiac mortality among patients who develop a first-episode ACS.
Keywords
Acute coronary syndrome, Cardiac mortality, Hypertension, Ischemic heart disease, Optimal cardio – vascular medication
Article Information
Disclosure
Financial support: No grants or funding have been received for this study.
Correspondence
Călin Pop George Cosbuc Street nr 31 Baia Mare, Romania medicbm@yahoo.com
Further Resources
Trending Topic
Hypertension (HTN) is one of the largest contributors to cardiovascular (CV) morbidity and mortality in the USA and is estimated to affect 47% of the adult population or approximately 122 million adults older than 20 years of age.1Â Recent estimates suggest that over 40% of these patients continue to have uncontrolled blood pressure (BP) and that […]
Atrial fibrillation (AF) is one of the most common arrhythmias. It affected 33.5 million people worldwide in 2010, a number that is expected to double by 2050.1Â AF prevalence increases with age, and approximately 25% of individuals aged 40 years or older will develop AF ...
Hypertension is a global health problem, with an estimated 1.13 billion individuals affected.1 Patients with hypertension, especially when resistant to conventional therapy, are at high risk of sequelae, e.g., ischaemic heart disease, haemorrhagic and ischaemic stroke, cardiac failure, peripheral vascular ...
...
...
...
...
...
...
...
...
...
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
